The effect of drug lipophilicity on P-glycoprotein-mediated colchicine efflux at the blood-brain barrier

被引：0
|
作者：
Khan, EU [1 ]
Reichel, A
Begley, DJ
Roffey, SJ
Jezequel, SG
Abbott, NJ
机构：
[1] Univ London Kings Coll, Dept Physiol, London WC2R 2LS, England
[2] Pfizer, Sandwich, Kent, England
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 1998年 / 36卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：84 / 86
页数：3
相关论文
共 50 条
  • [41] IN-VIVO AND IN-VITRO EVIDENCE FOR ATP-DEPENDENCY OF P-GLYCOPROTEIN-MEDIATED EFFLUX OF DOXORUBICIN AT THE BLOOD-BRAIN-BARRIER
    OHNISHI, T
    TAMAI, I
    SAKANAKA, K
    SAKATA, A
    YAMASHIMA, T
    YAMASHITA, J
    TSUJI, A
    BIOCHEMICAL PHARMACOLOGY, 1995, 49 (10) : 1541 - 1544
  • [42] Challenges of Using In Vitro Data for Modeling P-Glycoprotein Efflux in the Blood-Brain Barrier
    Sjostedt, Noora
    Kortejarvi, Hanna
    Kidron, Heidi
    Vellonen, Kati-Sisko
    Urtti, Arto
    Yliperttula, Marjo
    PHARMACEUTICAL RESEARCH, 2014, 31 (01) : 1 - 19
  • [43] Challenges of Using In Vitro Data for Modeling P-Glycoprotein Efflux in the Blood-Brain Barrier
    Noora Sjöstedt
    Hanna Kortejärvi
    Heidi Kidron
    Kati-Sisko Vellonen
    Arto Urtti
    Marjo Yliperttula
    Pharmaceutical Research, 2014, 31 : 1 - 19
  • [44] Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study
    De Vries, Erik F. J.
    Doorduin, Janine
    Vellinga, Namkje A. R.
    Van Waarde, Aren
    Dierckx, Rudi A.
    Klein, Hans C.
    NUCLEAR MEDICINE AND BIOLOGY, 2008, 35 (04) : 459 - 466
  • [45] Distribution of STI-571 to the brain is limited by P-glycoprotein-mediated efflux
    Dai, HQ
    Marbach, P
    Lemaire, M
    Hayes, M
    Elmquist, WF
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (03): : 1085 - 1092
  • [46] P-Glycoprotein, a gatekeeper in the blood-brain barrier
    Division of Experimental Therapy, Netherlands Cancer Inst., P., 1066 CX Amsterdam, Netherlands
    Adv. Drug Deliv. Rev., 2-3 (179-194):
  • [47] Pharmacokinetic consequences of active drug efflux at the blood-brain barrier
    Syvänen, S
    Xie, RJ
    Sahin, S
    Hammarlund-Udenaes, M
    PHARMACEUTICAL RESEARCH, 2006, 23 (04) : 705 - 717
  • [48] The ABC of the Blood-Brain Barrier - Regulation of Drug Efflux Pumps
    Mahringer, Anne
    Ott, Melanie
    Reimold, Isolde
    Reichel, Valeska
    Fricker, Gert
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (26) : 2762 - 2770
  • [49] P-glycoprotein, a gatekeeper in the blood-brain barrier
    Schinkel, AH
    ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (2-3) : 179 - 194
  • [50] Inhibition of P-glycoprotein-mediated efflux by thiolated cyclodextrins
    Veider, Florina
    Haddadzadegan, Soheil
    Armengol, Eva Sanchez
    Laffleur, Flavia
    Kali, Gergely
    Bernkop-Schnuerch, Andreas
    CARBOHYDRATE POLYMERS, 2024, 327
12345